1. Home
  2. RDHL vs JTAI Comparison

RDHL vs JTAI Comparison

Compare RDHL & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • JTAI
  • Stock Information
  • Founded
  • RDHL 2009
  • JTAI 2018
  • Country
  • RDHL Israel
  • JTAI United States
  • Employees
  • RDHL N/A
  • JTAI N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • RDHL Health Care
  • JTAI Finance
  • Exchange
  • RDHL Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • RDHL 8.2M
  • JTAI 7.1M
  • IPO Year
  • RDHL N/A
  • JTAI N/A
  • Fundamental
  • Price
  • RDHL $5.85
  • JTAI $2.52
  • Analyst Decision
  • RDHL
  • JTAI
  • Analyst Count
  • RDHL 0
  • JTAI 0
  • Target Price
  • RDHL N/A
  • JTAI N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • JTAI 160.0K
  • Earning Date
  • RDHL 04-07-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • RDHL N/A
  • JTAI N/A
  • EPS Growth
  • RDHL N/A
  • JTAI N/A
  • EPS
  • RDHL N/A
  • JTAI N/A
  • Revenue
  • RDHL $3,707,000.00
  • JTAI $15,028,926.00
  • Revenue This Year
  • RDHL $224.90
  • JTAI $21.49
  • Revenue Next Year
  • RDHL $82.69
  • JTAI $10.05
  • P/E Ratio
  • RDHL N/A
  • JTAI N/A
  • Revenue Growth
  • RDHL N/A
  • JTAI 46.66
  • 52 Week Low
  • RDHL $5.41
  • JTAI $2.30
  • 52 Week High
  • RDHL $20.28
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • JTAI 33.13
  • Support Level
  • RDHL $5.80
  • JTAI $2.30
  • Resistance Level
  • RDHL $6.26
  • JTAI $2.60
  • Average True Range (ATR)
  • RDHL 0.31
  • JTAI 0.28
  • MACD
  • RDHL 0.01
  • JTAI 0.01
  • Stochastic Oscillator
  • RDHL 19.33
  • JTAI 15.15

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: